Xiidra 5 % (Lifitegrast SOLUTION) 5 %

XIIDRA 5% is an ophthalmic solution containing lifitegrast, designed for eye care. It is commonly used to relieve symptoms of dry eye disease. This solution aims to provide comfort and support eye health.

Strength

5 %

Manufacturer / TM Owner

BAUSCH & LOMB INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

XIIDRA 5% is primarily used for the treatment of dry eye disease. It works by addressing the inflammation and discomfort associated with this condition. People often ask, 'What is XIIDRA 5% used for?' and the answer lies in its ability to provide relief from dry, irritated eyes. This ophthalmic solution is designed to improve eye moisture and reduce symptoms like redness and itching.

Side Effects

Common effects of XIIDRA 5% may include temporary burning or stinging upon application. Some users might experience a mild irritation or blurred vision shortly after use. These effects are generally short-lived and should subside quickly. If persistent or severe, it is advisable to consult a healthcare professional.

Precautions & Warnings

When using XIIDRA 5%, it is important to follow the prescribed instructions carefully. Avoid touching the tip of the dropper to prevent contamination. If you wear contact lenses, remove them before applying the solution and wait at least 15 minutes before reinserting them. Store the solution at room temperature and keep it out of reach of children.

Avoid Interactions

XIIDRA 5% may interact with other eye medications. It is advisable to inform your healthcare provider about all the medications you are currently using. Avoid using other eye drops or ointments within 15 minutes of applying XIIDRA 5%. Always consult a healthcare professional before combining treatments.

Frequently Asked Questions

XIIDRA 5% is used to relieve symptoms of dry eye disease, such as irritation and inflammation.

Store XIIDRA 5% at room temperature and keep it away from direct sunlight and out of reach of children.

Remove contact lenses before applying XIIDRA 5% and wait at least 15 minutes before reinserting them.

Common side effects may include temporary burning, stinging, or blurred vision.

The frequency of use depends on the prescription. Follow the instructions provided by your healthcare professional.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.